Modafinil decreases hypersomnolence in the English bulldog, a natural animal model of sleep-disordered breathing

Sleep

Volumn 19, Issue 8, 1996, Pages 626-631

  Panckeri, Karen A ^a   Schotland, Helena M ^b   Pack, Allan I ^b   Hendricks, Joan C ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Animal model; English bulldog; Hypersomnolence; Modafinil; Sleep disordered breathing

Indexed keywords

MODAFINIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AROUSAL; ARTERIAL GAS; ARTERIAL OXYGEN SATURATION; ARTICLE; BREATHING DISORDER; CONTROLLED STUDY; DOG; HYPERSOMNIA; INTRAVENOUS DRUG ADMINISTRATION; LATENT PERIOD; NONHUMAN; PRIORITY JOURNAL; REM SLEEP; SLEEP DISORDER; WAKEFULNESS;

EID: 0029845065     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/19.8.626     Document Type: Article

References (44)

1. Hendricks JC, Kovalski RJ, O'Brien JA, Morrison AR, Pack AI. The English bulldog: a natural model of sleep disordered breathing. J Appl Physiol 1987;63:1344-50.
2. Guilleminault C, VanderHoed J, Mitler MM. Clinical overview of the sleep apnea syndromes. In: Guilleminault C, Dement WC, eds. Sleep apnea syndromes. New York: Alan R Liss; 1978:1-12.
3. Bastuji H, Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry 1988;12:695-700.
4. Boivin DB, Montplaisir J, Petit D, Lambert C, Lubin S. Effects of modafinil on symptomatology of human narcolepsy. Clin Neuropharmacol 1993;16:46-53.
5. Mitler MM, Hajdukovic R. Relative efficacy of drugs for the treatment of sleepiness in narcolepsy. Sleep 1991;14:218-20.
6. Lyons TJ, French J. Modafinil: the unique properties of a new stimulant. Aviat Space Environ Med 1991;62:432-5.
7. Saletu B, Frey R, Krupka M, Anderer P, Grunberger J, Barbanoj MJ. Differential effects of a new central adrenergic agonist modafinil and d-amphetamine on sleep and early morning behavior in young healthy volunteers. Int J Clin Pharmacol Res 1989;9: 183-95.
8. Billiard M, Besset A, Montplaisir J, et al. Modafinil - a double-blind multicentric study. Sleep 1994;17:5107-12.
9. Laffont F, Mayet G, Minz M. Modafinil in diurnal sleepiness-a study of 123 patients. Sleep 1994;17:S113-5.
10. Homeyer P, Arnulf I, Garma G, Derenne JP. Modafinil in obstructive sleep apnea syndrome (OSAS): a controlled cross-over study in 6 patients. Sleep Res 1995;24:250.
11. Lagarde D, Batejat D, VanBeers P, Sarafin D, Pradella S. Interest of modafinil, a new psychostimulant, during a 60 hour sleep-deprivation experiment. Fundam Clin Pharmacol 1995;9:271-9.
12. Hermant JF, Rambert FA, Duteil J. Awakening properties of modafinil: effect on nocturnal activity in monkeys after acute and repeated administration. Psychopharmacology 1991;103: 28-32.
13. Lagarde D, Milhaud C. Electroencephalographic effects of modafinil, an alpha-1 adrenergic psychostimulant, on the sleep of rhesus monkeys. Sleep 1990;13:441-8.
14. Lin JS, Roussel B, Akaoka H, Fort P, Debilly G, Jouvet M. Role of catecholamines in modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 1992;591:319-26.
15. Milhaud C, Lagarde D. Effects of modafinil, an alpha one adrenergic type psychostimulant on the sleep of monkeys. Psychopharmacology 1988;96:294 (abstract).
16. Rambert FA, Pessonnier L, Duteil J. Modafinil, amphetamine, and methylphenidate-induced hyperactivities in mice involve different mechanisms. Eur J Pharmacol 1990;183:455-6.
17. Duteil J, Rambert FA, Pessonnier L, Hermant JF, Gombert R, Assous E. Central alpha-1 adrenergic stimulation in relation to the behavior stimulating effect of modafinil: studies with experimental animals. Eur J Pharmacol 1990;180:49-58.
18. Simon P, Panissaud C, Costentin J. The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. Psychopharmacology 1994;114:597-600.
19. Simon P, Hemet C, Ramassamy C, Costentin J. Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice. Eur Neuropsychopharmacol 1995;5:509-14.
20. Shelton J, Nishino S, Vaught J, Dement WC, Mignot E. Comparative effects of amphetamine and modafinil on cataplexy and daytime sleepiness in narcoleptic canines. Sleep Res 1994;23: 83.
21. Shelton J, Nishino S, Vaught J, Dement WC, Mignot E. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs. Sleep 1995;18: 817-26.
22. Touret M, Sallanon-Moulin M, Jouvet M. Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat. Neurosci Lett 1995;189:43-6.
23. Civil RH, Gorman SH, Stong DB, King SP. Safety, tolerance and pharmacokinetics of single doses of modafinil in healthy subjects. Sleep Res 1995;24:41.
24. Tanganelli S, Fuxe K, Ferraro L, Janson AM, Bianchi C. Inhibitory effects of the psychoactive drug modafinil on γ-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig: possible involvement of 5-hydroxytrytamine mechanisms. Naunyn Schmiedebergs Arch Pharmacol 1992;345:461-5.
25. Tanganelli S, Delamora MP, Ferraro L, et al. Modafinil and cortical gamma-aminobutyric acid outflow modulation by 5-hydroxytryptamine neurotoxins. Eur J Pharmacol 1995;273:63-71.
26. Ueki A, Rosen L, Andbjer B, et al. The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after partial transection of the dopamine pathway. Exp Brain Res 1993;93:259-70.
27. Fuxe K, Janson AM, Rosen L, et al. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis. Exp Brain Res 1992;88:117-30.
28. Nishino S, Sampathkumaran R, Tafti M, et al. Is presynaptic activation of dopaminergic transmission important for the EEG arousal effect of stimulants? Sleep Res 1995;24:310.
29. Strohl KP, Cherniack NS, Gothe B. Physiological basis of therapy for sleep apnea. Am Rev Respir Dis 1986;134:791-802.
30. Rapoport DM. Treatment of sleep apnea syndromes. Mt Sinai J Med 1994;61:123-30.
31. Brownell LG, West P, Sweatman P, Acres JC, Kryger MH. Protriptyline in obstructive sleep apnea. N Engl J Med 1982;307: 1037-42.
32. Smith PL, Haponik EF, Allen RP, Bleecker ER. Effect of protriptyline in sleep-disordered breathing. ARRD 1983;127:8-13.
33. Conway WA, Zorick F, Piccione P, Roth T. Protriptyline in the treatment of sleep apnea. Thorax 1992;37:49-53.
34. Findley LJ, Wilhoit SC, Suratt PM. Apnea duration and hypoxemia during REM sleep in patients with obstructive sleep apnea. Chest 1985;87:432-41.
35. Kopelman PG, Elliott M, Simonds A, Cramer D, Ward S, Wedzicha JA. Short term use of fluoxetine in asymptomatic obese subjects with sleep-related hypoventilation. Int J. Obes 1992;16: 825-30.
36. Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 1991;100: 416-21.
37. Guilleminault C, Stoohs R, Clark A, Simmons J, Labanowski M. From obstructive sleep apnea syndrome to upper airway resistance syndrome: consistency of daytime sleepiness. Sleep 1992;15:513-6.
38. Meurice JC, Dore P, Paquereau J, et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 1994;105: 429-33.
39. Ripberger R, Pirsig W. Long-term compliance with nasal CPAP for obstructive sleep apnea - a prospective study in 50 patients. Laryngorhinootologie 1994;73:581-5.
40. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:887-95.
41. Kribbs NB, Pack AI, Kline LR, et al. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147: 1162-8.
42. Montplaisir J, Bedard MA, Richer F, Rouleau I. Neurobehavioral manifestations in obstructive sleep apnea syndrome before and after treatment with continuous positive airway pressure. Sleep 1992;15:S17-19.
43. Bedard MA, Montplasir J, Richer F, Rouleau I, Malo J. Obstructive sleep apnea: pathogenesis of neuropsychological deficits. J Clin Exp Neuropsychol 1991;13:950-64.
44. Findley LJ. Driving performance and auto accidents in patients with sleep apnea. Clin Chest Med 1992;13:427-35.